Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Kronos Bio Inc (NASDAQ: KRON) closed the day trading at $0.96 up 1.05% from the previous closing price of $0.95. In other words, the price has increased by $1.05 from its previous closing price. On the day, 0.88 million shares were traded. KRON stock price reached its highest trading level at $0.9999 during the session, while it also had its lowest trading level at $0.9575.
Ratios:
For a better understanding of KRON, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.24 and its Current Ratio is at 7.24. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Berenberg on September 14, 2022, initiated with a Buy rating and assigned the stock a target price of $12.
On June 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $35.H.C. Wainwright initiated its Buy rating on June 24, 2021, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 21 ’24 when Frisbee Allison sold 12,105 shares for $1.05 per share. The transaction valued at 12,757 led to the insider holds 204,510 shares of the business.
Lin Charles Y sold 12,036 shares of KRON for $12,685 on Feb 21 ’24. The SR VP, RESEARCH & DEVELOPMENT now owns 234,603 shares after completing the transaction at $1.05 per share. On Feb 21 ’24, another insider, Olek Elizabeth A, who serves as the SR VP, CLINICAL SCIENCE of the company, sold 7,368 shares for $1.05 each. As a result, the insider received 7,765 and left with 193,275 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KRON now has a Market Capitalization of 57691200 and an Enterprise Value of -87033784. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.17 while its Price-to-Book (P/B) ratio in mrq is 0.36. Its current Enterprise Value per Revenue stands at -13.841 whereas that against EBITDA is 0.756.
Stock Price History:
Over the past 52 weeks, KRON has reached a high of $2.29, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is -16.07%, while the 200-Day Moving Average is calculated to be -24.10%.
Shares Statistics:
Over the past 3-months, KRON traded about 345.77K shares per day on average, while over the past 10 days, KRON traded about 678790 shares per day. A total of 58.95M shares are outstanding, with a floating share count of 40.07M. Insiders hold about 33.32% of the company’s shares, while institutions hold 31.03% stake in the company. Shares short for KRON as of 1711584000 were 665007 with a Short Ratio of 1.92, compared to 1709164800 on 600421. Therefore, it implies a Short% of Shares Outstanding of 665007 and a Short% of Float of 1.4199998999999999.
